Filing Flows › Verastem (VSTM) › Q3 2026 › vs Q3 2025
Verastem (VSTM) Q3 2026 vs Q3 2025 (year over year)
Verastem's revenue rose $12.8M (+114%) from $11.2M in Q3 2025 to $24.0M in Q3 2026.
Verastem, Q3 2026: revenue $24.0M (+114% year over year), operating margin -313.3%, net loss $74.7M, operating cash flow −$33.6M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $24.0M | $11.2M | $12.8M | +114% |
| Other income, net | $501K | −$57.8M | $58.3M | — |
| Net loss | $74.7M | $98.5M | −$23.8M | -24% |
| Costs & expenses | $99.2M | $110M | −$10.5M | -10% |
| Operating costs | $99.2M | $52.0M | $47.3M | +91% |
| Research & development | $68.8M | $29.0M | $39.8M | +137% |
| SG&A | $26.5M | $21.0M | $5.5M | +26% |
| Other operating costs | $3.9M | $2.0M | $2.0M | +101% |
| Operating cash sources | $74.7M | $98.2M | −$23.5M | -24% |
| Share-based compensation | $3.7M | $2.2M | $1.5M | +70% |
| Working capital & other | $37.4M | $59.8M | −$22.4M | -37% |
| Cash used in operations | $33.6M | $36.2M | −$2.6M | -7% |
| Net loss absorbed | $74.7M | $98.5M | −$23.8M | -24% |
Questions
How much did Verastem's revenue grow year over year in Q3 2026?
Verastem's revenue rose $12.8M (+114%) from $11.2M in Q3 2025 to $24.0M in Q3 2026.